The relationship between President Trump’s personal attorney, Michael Cohen, and Novartis (NVS) was more extensive than the drug maker previously disclosed, and the company issued misleading statements about the relationship, according to a report issued by Senate Democrats on Friday.

Dozens of emails and other documents revealed that the agreement between Cohen and Novartis was longer and more detailed than had been previously stated. Moreover, Novartis explicitly sought to hire Cohen to gain access to “key policymakers” and provided him with ideas for lowering drug costs, which later appeared in the Trump administration blueprint that was developed to address the issue.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Hopefully no one is too surprised. These corrupt corporations get what they pay for. No one seems to be paying attention to the uptick in Pharma advertising, including Advertorials in major media. It looks like Pharma now owns our regulatory boards, and our mass media. This is what a “Market Driven” healthcare industry looks like. The negative outcomes are just bad for business, or as they put it at the industry funded meetings, could lead to “liability.”

  • Hello Christopher,

    Alan Branson here with McaMoneyTree.com. We conduct business in all 50 states. What type of business do you have?

    McaMoneyTree.com provides funding for all types of businesses. There is no collateral required and funding is usually approved within 3-5 business days.

  • The depth of the information about this topic is being assessed, and there must be accountability for those who have been involved in this subterfuge.

    Hopefully, we will sooner than later be reading the outcome of the individual who were in collusion with the activities of what has to be addressed in a court of law, at least.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy